Assistant or Associate Professor, Oncology (Hematopoietic Cell Transplant and Immunotherapy Pro...
Assistant or Associate Professor, Oncology (Hematopoietic Cell Transplant and Immunotherapy Programs)
Mar 6, 2019
Hematopoietic Cell Transplant and Immunotherapy Programs
The Fred Hutchinson Cancer Research Center (Fred Hutch) and the University of Washington (UW) Department of Medicine are jointly recruiting a full-time faculty member at the Assistant Member/Assistant Professor or Associate Member/Associate Professor level without tenure due to funding (WOT), commensurate with experience and qualifications. in the Clinician-Scholar pathway in the Clinical Research Division of the Fred Hutch and the Clinician-Teacher pathway in the Division of Medical Oncology, Department of Medicine at the UW (12-month service period position). The primary appointment will be in the Clinical Research Division of Fred Hutch. The Fred Hutch, home of three Nobel laureates, is an independent, nonprofit research institution dedicated to the development and advancement of biomedical research to eliminate cancer and other potentially fatal diseases. Recognized internationally for its pioneering work in bone-marrow transplantation and immunotherapy, Fred Hutch and the UW provide a unique environment for conducting translational research and clinical care. The Fred Hutch, in collaboration with its clinical and research partners, the University of Washington and Seattle Children’s, is a National Cancer Institute-designated comprehensive cancer center.
The primary appointment will be in the Clinical Research Division of Fred Hutch. The selected individual for the advertised position is expected to enhance our clinical care and clinical research programs in hematopoietic cell transplantation and immunotherapy. University of Washington faculty engage in teaching, research and service.
Anticipated start date August 1, 2019.
The ideal candidate should have demonstrated experience in autologous or allogeneic hematopoietic cell transplantation and immunotherapy with an active clinical research interest, as demonstrated by peer reviewed publications, in the application of transplantation and immunotherapy to the treatment of human disease. All clinical research interests, including autologous stem cell transplantation, and CAR-T cell, TCR-T cell and TIL therapy, will be considered.
Applicants must have an MD degree (or foreign equivalent) and be American Board of Internal Medicine (ABIM) eligible or certified in Medical Oncology or Hematology (or foreign equivalent). Applicants with extensive research experience may alternatively be considered for physician/scientist appointments. In order to be eligible for University sponsorship for an H-1B visa, graduates of foreign (non-U.S.) medical schools must show successful completion of all three steps of the U.S. Medical Licensing Exam (USMLE), or equivalent as determined by the Secretary of Health and Human Services.
Interested candidates should submit a curriculum vitae, a concise statement of career goals including a description of clinical research goals, and list of personal references, along with a letter of application to: Dr. Marco Mielcarek and Dr. David Maloney.